Metastatic Cervical Cancer Terminated Phase 2 Trials for Cabozantinib (DB08875)

Also known as: Metastatic Cervical Cancers / Cervical Cancer Metastatic

IndicationStatusPhase
DBCOND0036674 (Metastatic Cervical Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04230954Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical CancerTreatment